Cargando…
Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review
The recent evolution of immunotherapy has revolutionised the treatment of hepatocellular carcinoma (HCC) and has led to new therapeutic standards. The advances in immunotherapy have been accompanied by the recognition of the role of the gut-liver axis in the progression of HCC but also of the clinic...
Autores principales: | Muscolino, Paola, Granata, Barbara, Omero, Fausto, De Pasquale, Claudia, Campana, Stefania, Calabrò, Alessia, D’Anna, Federica, Drommi, Fabiana, Pezzino, Gaetana, Cavaliere, Riccardo, Ferlazzo, Guido, Silvestris, Nicola, Speranza, Desirèe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486017/ https://www.ncbi.nlm.nih.gov/pubmed/37692859 http://dx.doi.org/10.3389/fonc.2023.1247614 |
Ejemplares similares
-
Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors
por: Drommi, Fabiana, et al.
Publicado: (2023) -
Drag cells in immunity: Plasmacytoid DCs dress up as cancer cells
por: Bonaccorsi, Irene, et al.
Publicado: (2014) -
The paradox of immunotherapy in NASH-HCC
por: Peng, Yao, et al.
Publicado: (2021) -
Harnessing neutrophil plasticity for HCC immunotherapy
por: Ramon-Gil, Erik, et al.
Publicado: (2023) -
Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
por: Bicer, Fuat, et al.
Publicado: (2023)